These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1642938)

  • 1. Use of mivacurium chloride by constant infusion in the anephric patient.
    Phillips BJ; Hunter JM
    Br J Anaesth; 1992 May; 68(5):492-8. PubMed ID: 1642938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of mivacurium chloride in patients with hepatic cirrhosis.
    Devlin JC; Head-Rapson AG; Parker CJ; Hunter JM
    Br J Anaesth; 1993 Aug; 71(2):227-31. PubMed ID: 8123397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neuromuscular recovery following mivacurium is predictable in patients with severe systemic disease prognoses].
    Blobner M; Busley R; Mann R; Jelen-Esselborn S; Kochs E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Oct; 34(10):638-41. PubMed ID: 10548961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery from mivacurium block with or without anticholinesterase following continuous infusion in obstetric patients.
    Jan GS; Tong WN; Chan AM; Hui TW; Lo JW
    Anaesth Intensive Care; 1996 Oct; 24(5):585-9. PubMed ID: 8909671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of mivacurium block with or without anticholinesterases following administration by continuous infusion.
    Maddineni VR; Mirakhur RK; McCoy EP
    Anaesthesia; 1994 Nov; 49(11):946-8. PubMed ID: 7802237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamics and the plasma concentration of mivacurium during spontaneous recovery and neostigmine-facilitated recovery.
    Lien CA; Belmont MR; Wray Roth DL; Okamoto M; Abalos A; Savarese JJ
    Anesthesiology; 1999 Jul; 91(1):119-26. PubMed ID: 10422936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular and clinical effects of mivacurium chloride in healthy adult patients during nitrous oxide-enflurane anaesthesia.
    Goldhill DR; Whitehead JP; Emmott RS; Griffith AP; Bracey BJ; Flynn PJ
    Br J Anaesth; 1991 Sep; 67(3):289-95. PubMed ID: 1832920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of mivacurium neuromuscular block: neostigmine versus edrophonium.
    Devcic A; Munshi CA; Gandhi SK; Kampine JP
    Anesth Analg; 1995 Nov; 81(5):1005-9. PubMed ID: 7486038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuromuscular and cardiovascular effect of mivacurium in anesthesia induction in patients with renal failure].
    Blobner M; Jelen-Esselborn S; Mann R; Kling M; Schneider G; Schneck HJ; Kochs E
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Feb; 31(1):15-21. PubMed ID: 8868527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery from mivacurium-induced neuromuscular blockade after neurosurgical procedures of long duration.
    Jellish WS; Thalji ZA; Murdoch JR
    J Clin Anesth; 1995 Dec; 7(8):643-7. PubMed ID: 8747563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neostigmine requirements for reversal of neuromuscular blockade following an infusion of mivacurium.
    Lessard MR; Trépanier CA; Rouillard JF
    Can J Anaesth; 1997 Aug; 44(8):836-42. PubMed ID: 9260011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neostigmine and edrophonium. Antagonism of profound and shallow mivacurium blockade].
    Bartunek A; Gilly H; Huemer G; Yildiz S; Schramm W; Lackner FX; Foldes FF
    Anaesthesist; 1997 Feb; 46(2):96-100. PubMed ID: 9133184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reversal of profound mivacurium-induced neuromuscular blockade.
    Kao YJ; Le ND
    Can J Anaesth; 1996 Nov; 43(11):1128-33. PubMed ID: 8922768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of halothane, enflurane and isoflurane on the pharmacodynamics of mivacurium in children].
    Neidhart G; Pabelick C; Kuhn I; Leuwer M; Vettermann J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Jun; 31(5):293-7. PubMed ID: 8767242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology of mivacurium in pediatric patients less than off years old during nitrous oxide-halothane anesthesia.
    Woelfel SK; Brandom BW; McGowan FX; Cook DR
    Anesth Analg; 1993 Oct; 77(4):713-20. PubMed ID: 8214654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium.
    Ali HH; Savarese JJ; Embree PB; Basta SJ; Stout RG; Bottros LH; Weakly JN
    Br J Anaesth; 1988 Nov; 61(5):541-6. PubMed ID: 2905143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Edrophonium antagonism of intense mivacurium-induced neuromuscular block in children.
    Abdulatif M; Al-Ghamdi A; Al-Sanabary M; Abdel-Gaffar ME
    Br J Anaesth; 1996 Feb; 76(2):239-44. PubMed ID: 8777104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mivacurium infusion requirements following vecuronium: different response between adults and children.
    Denman W; Goudsouzian N
    Can J Anaesth; 1995 Jul; 42(7):597-602. PubMed ID: 7553995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neostigmine but not edrophonium prolongs the action of mivacurium.
    Symington MJ; Mirakhur RK; Kumar N
    Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased mivacurium constant infusion requirements with defasciculating doses of pancuronium.
    Wangler MD; Thapar P; Skerman JH
    Anesth Analg; 1997 Mar; 84(3):668-71. PubMed ID: 9052321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.